|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) Washington DC VA Medical Center Home |
|---|---|
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000332 |
Purpose
The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.
| Condition | Intervention | Phase |
|---|---|---|
|
Cocaine-Related Disorders |
Drug: Nimodipine |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | High Dose Nimodipine Pharmacotherapy Adjunct |
Eligibility| Ages Eligible for Study: | 22 Years to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations| United States, District of Columbia | |
| Washington DC VA | |
| Washington, District of Columbia, United States, 20422 | |
| Principal Investigator: | Steven Deutsch, M.D. | Washington DC VA |
More Information
| Study ID Numbers: | NIDA-3-0009-1, Y01-3-0009-1 |
| Study First Received: | September 20, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000332 |
| Health Authority: | United States: Federal Government |
|
Cocaine-Related Disorders Calcium, Dietary Mental Disorders |
Substance-Related Disorders Nimodipine Disorders of Environmental Origin |
|
Membrane Transport Modulators Vasodilator Agents Molecular Mechanisms of Pharmacological Action Therapeutic Uses |
Calcium Channel Blockers Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |
